+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Body Fluid Collection and Diagnostic Market by Sample Type, Product, Application, Technology (Polymerase Chain Reaction, Next Generation Sequencing, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717258
The body fluid collection and diagnostic market size is estimated to be USD 30,525.12 million in 2022 and is expected to witness a CAGR of 7.87% during the forecast period 2023-2033. Surge in demand for the analysis of body fluids in a variety of clinical and diagnostic applications and increasing incidence of both communicable and non-communicable diseases worldwide are factors contributing to the market growth. Furthermore, rising demand for Direct-to-Consumer testing (DTC) and strategic partnership, launching new products, and expanding into new regions by key market players are other factors supporting the market growth. However, lack of skilled workforce and high price of instruments are expected to hinder the growth.

Rising demand for Direct-to-Consumer testing (DTC) is expected to fuel the market growth during the projected period. It is anticipated that the rising demand for Direct-to-Consumer testing (DTC) will increase demand for body fluid collection and make it simpler for end users to gather samples. A number of players directly sell DTC sample collection kits to consumers and then analyse the samples they collect. For instance, in April 2022, Labcorp and Getlabs introduced a cutting-edge healthcare service with the goal of making it simple for customers to get tested at home. When it is convenient for them, people can schedule a home blood samples collection.

Strategic partnership, launching new products, and expanding into new regions by key market players is predicted to propel the market growth during the forecast period. For instance, Roche announced in December 2022 that U.S. FDA has approved their Cerebrospinal Fluid (CSF) assays for Alzheimer's disease. These assays would be used to test for Alzheimer's disease biomarkers. Similar to this, C2N Diagnostics reported the success of the PrecivityAD Blood Test in October 2022, which can help doctors diagnose Alzheimer's disease.

By Sample Type

The market is categorized into saliva, blood, cerebrospinal fluid, and urine. In the global market, the blood segment accounted for the largest revenue share in 2022 owing to the development of cutting-edge techniques including single-nucleotide polymorphism analysis, short tandem repeat, and others. Body fluid remains found at crime scenes are critical pieces of evidence for forensic investigators. They include valuable DNA data that can be used to identify a victim or suspect. One of the key areas of forensics is crime scene analysis. To increase diagnostic blood collection, BD and Babson Diagnostics expanded their collaboration in May 2022. Patients might obtain blood samples at home due to the new care setting. The urine sample is predicted to exhibit significant growth in the upcoming years. The use of medical testing in the diagnosis and treatment of diseases is increasing in significance. Urine is collected for various purposes, including the metabolic assessment of proteinuria, urinary stone disease, estimating renal function, and more. In an outpatient setting, the testing is conducted. University of Tokyo researchers announced in November 2022 that they are developing new tests that could aid in the early detection of chronic kidney disease. The segment's growth would be further fuelled by ongoing developments in this area.

By Product

The market is divided into instruments, tests/services, and kits & consumables. In 2022, the kits & consumables segment accounted for the highest revenue share due to the less restrictions on COVID-19 kits from the government and rising demand for quick and affordable kits. For instance, the Indian Council of Medical Research approved COVID home test kits in May 2021 and published comprehensive instructions on how and for whom to use the kits. The CoviSelfTM COVID-19 OTC device was created by Mylab Discovery Solutions Ltd, and its operation is guided by a smartphone app. The instruments market is expected to experience rapid expansion in the upcoming years. In order to provide the greatest quality of insights, laboratories have replaced the manual cell counting process with analyzer-based body fluid analysis. Additionally, it will be beneficial for laboratories that have heavy sample loads every day. The BC-700 Series, an Integrated ESR & CBC Hematology Analyzer for Small-to-Middle Sized Labs, announced by Mindray for release in March 2022. However, the analyzer's price is very high, thus laboratories opt to employ standard haematology analyzers for fluid cell counts.

By Application

The market is segregated into therapeutic decision making, prognostics & screening, and diagnostics & monitoring. In the global market, the segment accounted for the largest revenue share in 2022 owing to the fact that it enables clinicians to detect changes to cellular networks and physiological situations. Clinical indicators are regarded to be best derived from body fluid of humans. Body fluid testing has benefits for disease diagnosis and monitoring, including low cost, low invasiveness, and speedy sample collection and processing. Furthermore, molecular expression level profiles in body fluid can help in detecting alterations in cellular networks and physiological situations in damaged tissues. One of the most effective methods for early diagnosis, monitoring, management, and evaluation of the early response to chronic diseases, and for determining the potential pathophysiology of such abnormalities, is now recognized to be body fluid analysis. Therapeutic decision-making is expected to expand profitably during the forecast period. Involving the patient in therapeutic decision-making emphasizes the advantages and disadvantages of the course of treatment.

By Technology

The market is segmented into polymerase chain reaction (PCR), next generation sequencing (NGS), fluorescence in situ hybridization (FISH), and others. In 2022, the polymerase chain reaction (PCR)segment accounted for the largest revenue share owing to increasing use of the technology for the identification of diseases. A non-invasive method for diagnosing infectious diseases and genetic abnormalities is body fluid DNA sequencing. For the robust amplification of small DNA fragments in body fluid, Oligo-Primed Polymerase Chain Reaction can be used. The current Ebola virus disease outbreak was reported by the Democratic Republic of the Congo's Ministry of Health in August 2022. As a result, RT-PCR has experienced an increase in demand in laboratories for virus detection. The oropharyngeal secretions are used as the source for the sample. The next-generation sequencing segment is expected to exhibit the fastest rate of growth in the upcoming years. Every aspect of biological science has been changed by NGS. The cost of sequencing has been greatly decreased. This segment has undergone a number of developments recently, which have driven the growth of the segment. For its NGS 'phenotyping' platform for sterile body fluid samples and positive blood cultures, Selux Diagnostics, Inc. gained FDA approval in September 2021. Rapid antimicrobial susceptibility testing (AST) for particular sample types can be performed using a single platform.

Regional Markets

In 2022, North America region accounted for the highest revenue in the body fluid collection and diagnostic market and is expected to maintain its dominance during the forecast period. This is attributed to the number of innovations, including product releases and collaborative strategic plans between companies. In order to provide the URO17 non-invasive urine test for bladder cancer in the United States, KDx Diagnostics Inc. and UroGPO agreed into a partnership agreement in May 2022. Similar to this, Psomagen Inc. launched at-home saliva collection kits in July 2021 to expand its COVID-19 diagnostic services and broaden its product offering. The Asia Pacific region is expected to experience the fastest growth during the projection period. The market for body fluid diagnostics and collection is witnessing growing demands as the incidence of diseases including cancer, cardiovascular conditions, and other rare disorders increases. Roche Diagnostics stated in November 2022 that it would introduce its first automated cerebrospinal fluid (CSF)-based Alzheimer's disease test in India.

Competitor Insights

Some of the key players operating in the body fluid collection and diagnostic market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, QIAGEN N.V., Inc., Guardant Health, Johnson & Johnson, Laboratory Corporation of America Holdings, Biocept Inc., Illumina, F. Hoffmann-La Roche Ltd., and MDxHealth SA.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, Mount Sinai and Exosome Diagnostics came into a partnership agreement in August 2022 to further the study and development of real-time nucleic acid-based body-fluid diagnostics and to advance customized medicine.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including sample type, product, application, and technology from 2023 to 2033.

Segmentation: Body Fluid Collection and Diagnostic Market Report 2022 - 2033

Sample Type (Revenue, USD Million), 2022 - 2033

  • Saliva
  • Blood
  • Cerebrospinal Fluid
  • Urine

Product (Revenue, USD Million), 2022 - 2033

  • Instruments
  • Tests/Services
  • Kits & Consumables

Application (Revenue, USD Million), 2022 - 2033

  • Therapeutic Decision Making
  • Prognostics & Screening
  • Diagnostics & Monitoring

Technology (Revenue, USD Million), 2022 - 2033

  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Fluorescence in situ hybridization (FISH)
  • Others

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Body Fluid Collection and Diagnostic

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Body Fluid Collection and Diagnostic Market

7. Market Analysis by Sample Type
7.1. Saliva
7.1.1. Saliva Market Forecast, 2022-2033 (USD Million)
7.2. Blood
7.2.1. Blood Market Forecast, 2022-2033 (USD Million)
7.3. Cerebrospinal Fluid
7.3.1. Cerebrospinal Fluid Market Forecast, 2022-2033 (USD Million)
7.4. Urine
7.4.1. Urine Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Product
8.1. Instruments
8.1.1. Instruments Market Forecast, 2022-2033 (USD Million)
8.2. Tests/Services
8.2.1. Tests/Services Market Forecast, 2022-2033 (USD Million)
8.3. Kits & Consumables
8.3.1. Kits & Consumables Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by Application
9.1. Therapeutic Decision Making
9.1.1. Therapeutic Decision Making Market Forecast, 2022-2033 (USD Million)
9.2. Prognostics & Screening
9.2.1. Prognostics & Screening Market Forecast, 2022-2033 (USD Million)
9.3. Diagnostics & Monitoring
9.3.1. Diagnostics & Monitoring Market Forecast, 2022-2033 (USD Million)

10. Market Analysis by Technology
10.1. Polymerase Chain Reaction (PCR)
10.1.1. Polymerase Chain Reaction (PCR) Market Forecast, 2022-2033 (USD Million)
10.2. Next Generation Sequencing (NGS)
10.2.1. Next Generation Sequencing (NGS) Market Forecast, 2022-2033 (USD Million)
10.3. Fluorescence in situ hybridization (FISH)
10.3.1. Fluorescence in situ hybridization (FISH) Market Forecast, 2022-2033 (USD Million)
10.4. Others
10.4.1. Others Market Forecast, 2022-2033 (USD Million)

10. Regional Market Analysis
10.2. Regional Market Trends

11. North America Body Fluid Collection and Diagnostic Market
10.1. North America Body Fluid Collection and Diagnostic Market
10.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.1.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
10.2. U.S. Body Fluid Collection and Diagnostic Market
10.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.2.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
10.3. Canada Body Fluid Collection and Diagnostic Market
10.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.3.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)

11. Europe Body Fluid Collection and Diagnostic Market
11.1. Europe Body Fluid Collection and Diagnostic Market
11.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.1.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.2. Germany Body Fluid Collection and Diagnostic Market
11.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.2.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.3. UK Body Fluid Collection and Diagnostic Market
11.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.3.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.4. France Body Fluid Collection and Diagnostic Market
11.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.4.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.4.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.5. Spain Body Fluid Collection and Diagnostic Market
11.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.5.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.6. Italy Body Fluid Collection and Diagnostic Market
11.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.6.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.6.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.7. Rest of EuropeBody Fluid Collection and Diagnostic Market
11.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.7.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.7.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)

12. Asia PacificBody Fluid Collection and Diagnostic Market
12.1. Asia PacificBody Fluid Collection and Diagnostic Market
12.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.1.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.2. Japan Body Fluid Collection and Diagnostic Market
12.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.2.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.3. China Body Fluid Collection and Diagnostic Market
12.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.3.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.4. India Body Fluid Collection and Diagnostic Market
12.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.4.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.5. South Korea Body Fluid Collection and Diagnostic Market
12.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.5.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.6. Australia Body Fluid Collection and Diagnostic Market
12.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
12.6.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
12.6.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.6.1.3. Market Size and Forecast by Application 2022-2033 (USD Million)
12.6.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.7. Rest of Asia Pacific Body Fluid Collection and Diagnostic Market
12.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.7.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
12.7.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.7.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.7.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)

13. Latin America Body Fluid Collection and Diagnostic Market
13.1. Latin America Body Fluid Collection and Diagnostic Market
13.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.1.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
13.2. BrazilBody Fluid Collection and Diagnostic Market
13.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
13.3. MexicoBody Fluid Collection and Diagnostic Market
13.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.3.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
13.4. Argentina Body Fluid Collection and Diagnostic Market
13.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.4.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
13.5. Rest of Latin America Body Fluid Collection and Diagnostic Market
13.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.5.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
13.5.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.5.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.5.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)

14. MEABody Fluid Collection and Diagnostic Market
14.1. MEA Body Fluid Collection and Diagnostic Market
14.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
14.1.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
14.1.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.1.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
14.2. GCC Body Fluid Collection and Diagnostic Market
14.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
14.2.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
14.2.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.2.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
14.3. South Africa Body Fluid Collection and Diagnostic Market
14.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
14.3.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
14.3.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.3.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)
14.4. Rest of MEA Body Fluid Collection and Diagnostic Market
14.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
14.4.1.1. Market Size and Forecast by Sample Type, 2022-2033 (USD Million)
14.4.1.2. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.4.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.4.1.4. Market Size and Forecast by Technology, 2022-2033 (USD Million)

15. Competitor Analysis
15.1. Market Share Analysis, 2022
15.2. Major Recent Developments, 2019-2022

16. Company Profiles
16.1. Thermo Fisher Scientific Inc.
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financial Analysis
16.1.4. Product Benchmarking
16.1.5. Recent Developments
16.2. Bio-Rad Laboratories
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financial Analysis
16.2.4. Product Benchmarking
16.2.5. Recent Developments
16.3. QIAGEN N. V. Inc.
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financial Analysis
16.3.4. Product Benchmarking
16.3.5. Recent Developments
16.4. Guardant Health
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financial Analysis
16.4.4. Product Benchmarking
16.4.5. Recent Developments
16.5. Johnson & Johnson
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financial Analysis
16.5.4. Product Benchmarking
16.5.5. Recent Developments
16.6. Laboratory Corporation of America Holdings
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financial Analysis
16.6.4. Product Benchmarking
16.6.5. Recent Developments
16.7. Biocept Inc.
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financial Analysis
16.7.4. Product Benchmarking
16.7.5. Recent Developments
16.8. Illumina
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financial Analysis
16.8.4. Product Benchmarking
16.8.5. Recent Developments
16.9. F. Hoffmann-La Roche Ltd.
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financial Analysis
16.9.4. Product Benchmarking
16.9.5. Recent Developments
16.10. MDxHealth SA
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financial Analysis
16.10.4. Product Benchmarking
16.10.5. Recent Developments
16.11. Company 11
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financials
16.11.4. Product Benchmarking
16.11.5. Recent Developments
16.12. Company 12
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financials
16.12.4. Product Benchmarking
16.12.5. Recent Developments
16.13. Company 13
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financials
16.13.4. Product Benchmarking
16.13.5. Recent Developments
16.14. Company 14
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financials
16.14.4. Product Benchmarking
16.14.5. Recent Developments
16.15. Company 15
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financials
16.15.4. Product Benchmarking
16.15.5. Recent Developments
16.16. Others Prominent Players

17. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories
  • QIAGEN N.V. Inc.
  • Guardant Health
  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • Biocept Inc.
  • Illumina
  • F. Hoffmann-La Roche Ltd.
  • MDxHealth SA